New Delhi, Jan. 23 -- Raising hopes, scientists of the School of Biochemical Engineering of IIT-BHU in collaboration with the Institute of Medical Sciences, BHU have tested a vaccine that halts the progress of the Kala Azar, a neglected tropical disease caused by Leishmania parasite.
Currently there is no vaccine yet available in the market for humans against this disease and the treatment depends on drugs with limitations which is a serious concern towards its complete elimination.
In India which has postponed Kala Azar disease elimination goal thrice with 2025 new deadline, 54 districts in Bihar, Jharkhand, Uttar Pradesh, and West Bengal are still affected by the disease with sporadic cases in other states like Assam, Himachal Pradesh, ...